Streetwise Reports' Article Archives — August 2022 back to current month (114)
Rare Earths Explorer Looks to Challenge China (08/31/2022)
This Canadian explorer is working toward a preliminary feasibility study at its Wicheeda rare earth element deposit in British Columbia.
Hannam & Partners launched coverage on this near-term producing company set to add proven helium assets in Alberta to its large helium property portfolio in Saskatchewan.
Despite the increase in cost assumptions for the company's joint venture project in Mexico, this mining company is positioned for "robust cash flow," noted a Stifel report.
Uranium Co. With Big Upside as the Sector Takes Off (08/31/2022)
In light of the world moving away from fossil fuels, expert Clive Maund reviews Azincourt Energy Corp.'s six-month, three-year, and 12-month charts to tell you whether he believes it is a Buy.
ChargePoint Boosts Network Charging Revenue by 106% (08/31/2022)
ChargePoint Holdings Inc. shares traded 14% higher after the company reported Q2/23 financial results that included a 93% YoY increase in revenue. The firm posted the first $100 million sales quarter in its history and affirmed its FY/23 revenue guidance for total revenues of $450-$500 million.
At least nine analysts continue to rate MAG Silver Corp. a Buy after positive second-quarter financials, even as it continues to wait for its electricity hookup at its new plant in Mexico.
With a 340% year-over-year increase in the price of lithium, raising cash for exploration is easier than it once was. One lithium junior just raised more than CA$3.3 million to bolster its lithium portfolio with another project in Argentina and continues exploration on a nearby project that borders a lithium project being developed by Rio Tinto.
FDA OKs Biopharma to Trial New Cell Therapy (08/30/2022)
Now with clearance, the firm plans to commence a Phase 1 study of its lead candidate in patients with lymphoma by the end of this year, noted an H.C. Wainwright & Co. report.
Royal Helium Ltd. News Ought To Get It Moving (08/30/2022)
Expert Clive Maund reviews the most recent news with Royal Helium Ltd., which has just signed a new supply agreement with a major space launch company.
Mining Co. Makes Progress Toward Needed Designation (08/30/2022)
A project site visit revealed the explorer is working to achieve this goal, necessary for an environmental certificate extension, Cantor Fitzgerald noted in a report.
Shares of OKYO Pharma Ltd. traded 23% higher after the company reported it intends to submit an IND to the U.S. FDA for its OK-101 for treating dry eye disease in Q4/22. Together with its manufacturing partner, AmbioPharm Inc., the firm is now preparing to initiate a phase 2 clinical study in Q1/23.
The developer of genetic medicines is taking six more months to conduct longer preclinical safety studies involving its lead therapeutic, noted an Oppenheimer report.
ACC Recommends Approved Drug for Lowering LDL (08/29/2022)
This same medicine is currently being evaluated in a global clinical trial from which topline results are expected in Q1/23, noted an H.C. Wainwright & Co. report.
Space Launch Co. Signs Offtake With Helium Explorer (08/29/2022)
One helium company in western Canada slated to launch helium production in Q1/23 just signed a helium offtake agreement with a 'space launch company.' Find out the name of the helium company and why its helium operations have a low carbon footprint.
Pharma Co. To Provide HHS With Smallpox Drug (08/29/2022)
Chimerix Inc. shares traded 8% higher after the company reported it has entered into a 10-year, $680 million contract with a U.S. Government health agency to deliver up to 1.7 million treatment courses of its TEMBEXA for use as a medical countermeasure for smallpox.
With this first such agreement and derisking milestone for the energy company, it "is expected to realize near-term cash flows," noted an Eight Capital report.
Expert Sees Lots of Positive Things for Tech Co. (08/28/2022)
Expert Clive Maund reviews the five-year and six-month charts for TraceSafe Inc. as well as its recent partnership with Solutions by stc.
Expert Says Mining Co. Looking 'Most Attractive' (08/26/2022)
In light of Silver X Mining Corp.'s significant rise in the price of its stock, expert Clive Maund reviews whether he believes the company is a good Buy.
Lithium Co. Announces More Positive Drill Results (08/26/2022)
These new data bode well for the upcoming resource update and prefeasibility study, expected by year-end, noted a Canaccord Genuity report.
A small biotech has taken further steps to deepen the intellectual property moat for its potentially revolutionary treatment for alcohol addiction. Find out which company it is and why one analyst has given it a CA$8 target price.
Shares of Nevada Copper Corp. traded 10% higher after the company reported it has lined up the necessary financing to restart production at its Pumpkin Hollow underground copper mine in Q2/23. The firm's plan calls for production hoisting rates to ramp up to 3,000 tpd in Q3/23 growing to 5,000 tpd in Q4/23.
Junior Sees Big Silver Samples at Colombia Property (08/25/2022)
Outcrop Silver & Gold Corp. sees unusually high surface sampling assays as it explores a new trend at its Santa Ana project in Colombia.
In light of Infinity Stone Ventures Corp.'s completion of its first tranche of financing, expert Clive Maund reviews the company to determine whether or not he would rate it a Buy.
PetroTal Corp. shares traded 11% higher after the company reported Q2/22 financial results highlighting seven consecutive quarters of production growth and reaffirmed its FY/22 guidance for average production of 15,000 bbl/d.
Green Tech Co. Helps Ranchers Turn Manure Into Money (08/24/2022)
Bion Environmental Technologies Inc. is transforming cattle manure into natural gas, organic fertilizer, and clean water, and helping ranchers grow sustainable organic beef.
Management's ongoing execution is raising the biopharma's profile among investors, noted an Oppenheimer report.
New data thus far from drilling the deposit suggest the future resource grade will exceed the historical one, noted a Research Capital Corp. report.
New Chemical Assays from U3O8 Asset Notable (08/24/2022)
These results confirm the owner of this Athabasca Basin project identified a shallow uranium deposit with economic potential there, noted a Research Capital Corp. report.
The U.S. Food and Drug Administration's follow-up to the new drug application for this potential treatment suggests a possible green light based on unmet medical need, noted a BTIG report.
GCM Mining, Have Your Gold and High Dividends Too (08/24/2022)
Historically, dividends make up about 50% of stock market returns, so they are important. Not often can you find a solid, growing gold company with stellar management that is also offering over a 5% dividend yield. Expert Ron Struthers reviews the latest updates in gold stocks as well as GCM Mining Corp.
Explorer Creating District-Scale Yukon Gold Project (08/24/2022)
Shares of Snowline Gold Corp. traded to a new 52-week intraday high after the company posted initial assay results from its Rogue Project's Valley Zone. Starting from just below bedrock, the firm reported that it intersected 2.3 g/t gold over 282.9 meters.
Three newly encountered high-grade areas indicate considerable upside at this precious metals mining project, noted a Research Capital Corp. report.
Expert Clive Maund looks at the six-month chart of TraceSafe Inc. to show how this stock can be both cheap and effective for its buyers.
Hedge Fund Doubles Position in Biotech Co. (08/23/2022)
A Canadian hedge fund doubled its stake in a tiny biotech that demonstrated promising results in a study that used a former Sanofi drug called Ifenprodil to treat idiopathic pulmonary fibrosis and chronic cough. Find out the name of the company and why one analyst has given it a 12-month CA$25 target price — a 560% increase from the unit price in its recent placement.
Expert Sees Even More 'Good News' From Pharma Co. (08/23/2022)
Expert Clive Maund reviews the latest news with Algernon Pharmaceuticals Inc., including the recent successful closing of its financing.
Mixed Results From Major Gold Companies (08/23/2022)
Expert Adrian Day reviews the quarterly earnings reports from the remaining precious metals companies on his list, including Wheaton Precious Metals and Franco Nevada, among others.
Silver Miner Posts Best Intercept to Date (08/23/2022)
Shares of AbraSilver Resource Corp. traded 13% higher after the company reported assay results from four recently completed holes during this year's Phase 2 drill program at the company's Diablillos silver-gold deposit in Argentina. The firm highlighted results from hole DDH-22-037, which returned 155m of 289 g/t Ag eq, including 30m of 609 g/t Ag eq.
Biotech Co. Has Multiple Shots on Goal (08/22/2022)
This developer of immunotherapies has a robust pipeline, several active clinical programs and, thus, numerous catalysts, noted an Oppenheimer report.
Price Target on Cancer Drug Co. Boosted (08/22/2022)
The price target was increased by 66% to reflect the full potential opportunity of the biopharma's drug candidate for hepatocellular carcinoma, a key driver going forward, noted an H.C. Wainwright & Co. report.
Drug Developer Initiates Ph. 3 STGD1 Trial (08/22/2022)
Shares of Belite Bio Inc. traded 19% higher after the company reported it has initiated a pivotal Phase 3 clinical study in the U.S. for its LBS-008 for use in treating Stargardt disease.
A Vancouver-based firm just announced a partnership with the biggest publicly traded IT company in Saudi Arabia as it looks to provide hardware-assisted software solutions for the multi-billion-dollar new Smart City buildout happening in the Middle East.
Analyst coverage was initiated on this Canadian mining explorer, which has significant land packages and multimillion ounces of gold in metals-rich areas of Papua New Guinea, noted a Jemini Capital report.
Solar Co. Exceeds Revenue Estimates in Q2 (08/19/2022)
Shares of Canadian Solar Inc. traded 15% higher yesterday to a new 52-week high after the company reported Q2/22 financial results that highlighted a 62% YoY increase in revenue and raised the ranges of its FY/22 revenue estimates by $500 million.
New Drill Data from Gold Project Boost Resources (08/19/2022)
Drill results Troilus Gold Corp. generated in the last four months at this property will be incorporated into the upcoming mineral resource update and prefeasibility study, noted a Haywood Securities report.
Biopharma Co. Gains FDA Approval for Oral MDD Drug (08/19/2022)
Shares of Axsome Therapeutics Inc. traded 39% higher after the company reported that the U.S. FDA granted approval for its AUVELITY™ making it the first oral N-methyl D-aspartate (NMDA) receptor antagonist authorized for treating major depressive disorder in adults.
One healthcare company in the U.K. is bringing its proprietary Ketamine-assisted treatment for Alcohol Use Disorder to Canada. It's the second deal the company has made with a North American clinic operator this week. Find out why this won't be the last one.
The government in Ecuador is on track to grant an environmental permit for BacTech Environmental Corp.'s new bioleaching plant in September, the company says.
Biotech Co. To Receive 66% Funding From UK Gov. (08/17/2022)
Expert Clive Maund reviews the latest update with Awakn Life Sciences Corp., including its recent rise in stock volume and the announcement that the company is to receive 66% funding support from the UK government for the development of its ketamine-assisted therapy treatment for alcohol use disorders.
Gold Co.'s Target Price Boosted by $5 Per Share (08/17/2022)
The new figure takes into account recently determined economics and upside of the world's largest undeveloped gold project along with future precious metals prices, noted a ROTH Capital Partners report.
Shares of Touchstone Exploration Inc. traded 16% higher after the company reported it received environmental approval for construction of a two hundred million cubic feet multi-well surface production facility in Trinidad.
Expert Chris Temple of The National Investor reviews the latest updates with Enterprise Group Inc., including the announcement of its second-quarter results.
This sale indicates the firm is continuing to forge a pathway into one of its large target markets, noted a Noble Capital Markets report.
B2B communications and marketing solutions firm DATA Communications Management Corp. has implemented a five-year, 14-point strategic plan aimed at transitioning clients from print to digital services. eResearch Corp. stated in a research update that the plan is expected to generate both top-line growth and robust EBITDA margin expansion and mentioned that during Q1/22 the company posted its largest quarterly YoY revenue growth in four years. eResearch stated that it is maintaining its Buy rating on the company with a 12-month price target of CA$4.00.
Junior Explorer Pivots to Critical Minerals, Metals (08/16/2022)
Rover Metals Corp. is not getting out of its gold projects but has an eye on the future with a critical minerals and metals project in the Northwest Territories.
In landing this first licensing deal, the life sciences firm "shows good progress towards a potentially high-margin business," noted a Stifel report.
Silver One Resources Inc. shares traded 14% higher after the silver mining firm reported that it intersected 48.77m of 332 g/t Ag and 0.39 g/t Au, which included 10.67m of 1,339 g/t Ag and 1.21 g/t Au and its Candelaria Project in west central Nevada.
Nuvectis Pharma Inc recently announced quarterly financial results and is continuing to advance its precision oncology programs. H.C. Wainwright & Co. LLC advised in an earnings update that the firm offers significant upside potential as it is rapidly advancing its drug candidates through clinical development and is looking for ways to expand to markets outside of the U.S. H.C. Wainwright stated that it is reiterating its Buy rating and $21 price target for Nuvectis Pharma.
Hematopoietic stem cell transplantation (HSCT) and gene therapy firm Magenta Therapeutics Inc. recently announced updates related to two of its leading clinical programs. BTIG LLC advised in a research update that it expects Magenta to release updated clinical data from its MGTA-117 and MGTA-145 programs in Q4/22, which will serve as key catalysts for the company. BTIG stated it is reiterating its "Buy" rating and $6/share price target on Magenta Therapeutics.
Biotech Co. Nearing Milestones for HBV Drugs (08/15/2022)
Arbutus Biopharma Corp. presented clinical data to an international liver disease conference showing that its AB-729 continues to deliver strong reductions in HBsAg. The company is now conducting three separate combination therapy studies of its AB-729 and expects to achieve important milestones when the initial data readouts are released in H2/22. H.C. Wainwright & Co. affirmed its Buy rating for Arbutus Biopharma and adjusted its price target to $7.50.
One analyst says this healthcare co. has the opportunity to generate attractive CAPEX-light, high margin SaaS-like recurring revenues, which investors are currently getting for free, after the biotech firm entered the US market for alcohol addiction treatment through off-label licensing deals with a network of treatment clinics.
Avivagen is an early-stage life sciences company with a patented product for immune support that causes dramatic and profitable improvements in livestock. They have been increasing their sales and market penetration at a dramatic rate, and I believe them to be at an inflection point. Research coverage is expecting a 7x return.
Rare Earths Co. Raises AU$45 Million (08/15/2022)
These funds, including US$30M from a strategic investor, should see Vital Metals Ltd. through extraction facility commissioning, now underway, noted an MST Access report.
Firm Sees Boost in Sales of Health Chewable for Dogs (08/15/2022)
Recent orders from Avivagen Inc. are helping the developer of this product build a recurring revenue stream, noted a Noble Capital Markets report.
Accelerate Diagnostics Inc. shares traded 25% higher after the company reported Q2/22 earnings and announced it entered into a commercial agreement with Becton, Dickinson and Co. that will allow it to deliver rapid antimicrobial identification and susceptibility diagnostics to clinicians and patients worldwide.
Mexican Silver Explorer Going For Gold in Chihuahua (08/13/2022)
The CEO of a junior silver explorer operating in Mexico’s Parral region believes its drill campaign revealed more than just promising gold-silver grades – he thinks his company is onto something much bigger. And that perhaps the entire camp is open to re-evaluation.
Lion One Gets 10-year Extension at Fiji Gold Project (08/12/2022)
One analyst believes a 10-year extension of a mining lease at a high-grade gold project in Fiji could put a junior gold play in the crosshairs of companies looking to add ounces.
Dolly Varden Silver Corp. releases results from the first hole in its 30,000-meter drilling campaign at its sprawling Kitsault Valley project in British Columbia.
This means the pads could be leached again, and cyanide solubility test results indicate the process could be done economically, noted a PI Financial report.
'Compelling' PFS Expected for Rare Earth Project (08/12/2022)
There is significant potential to expand Defense Metals Corp.'s current resource and extend the mine life, noted a Noble Capital Markets report.
With Enterprise Group Inc.'s stocks steadily improving, expert Clive Maund reviews the latest updates with the company, including news with its wholly owned subsidiary Evolution Power Projects Inc.
Energy services and specialty equipment rental supplier Enterprise Group Inc. reported earnings for Q2/22, which included a 64% YoY increase in revenue along with substantial growth in gross margins and adjusted EBITDA. The company is now heading into the busy peak winter drilling season with a new arsenal of natural gas fueled generators that enable oil and gas drillers and natural resource firms to greatly reduce on-site CO2 emissions, meet and exceed mandated ESG requirements, and in the process, save thousands of dollars per day by eliminating the need for diesel-powered generators.
Shares of Twin Vee PowerCats Co. traded 77% higher and reached a new 52-week high after the high horse-power sport and commercial watercraft manufacturer reported Q2/22 financial results highlighting a 158% YoY increase in revenue from its Gas-Powered Division.
The widespread use of antibiotics in animal feeds, as well as over-prescription by physicians for therapeutic treatment of human infections, is leading to a growing resistance to antibiotics that is killing close to 1 million people each year. One company believes it has developed at least part of the solution through a beta carotene food additive that boosts immunity and contributes to better overall health.
The significant growth potential of the project also enhances its profile as a takeout target, noted a ROTH Capital Partners report.
Co.'s 'Monster' Earnings Surpass Analyst's Forecast (08/11/2022)
Big earnings results posted by Data Communications Management Corp. have led an analyst to raise his target and estimates for the company.
Copper Update and a Promising Copper Stock (08/11/2022)
Expert Clive Maund reviews the latest updates in copper stocks and how he thinks this turnaround will effect copper company Infinitum Copper.
More resource companies released quarterly earnings, but since in all cases production and other items had been pre-released, there were few surprises for expert Adrian Day.
Canadian Marketing Co. Pivots From Print to Digital (08/10/2022)
One of Canada’s largest printing and marketing services company is growing its coffers by expanding its digital footprint.
Testing Confirms Drug Candidate Differs From Peers (08/10/2022)
Biotech ProMIS Neurosciences Inc.'s monoclonal antibody in development for Alzheimer's disease boasts a "unique" binding profile that could be "important to its clinical success," noted a Leede Jones Gable report.
Expert Clive Maund reviews the most recent updates from digital printing company Data Communications Management Corp. to tell you whether or not he believes it is a Buy.
With consumers moving away from artificial meat products and other preservatives, Avivagen Inc.'s antibiotic free animal feed seems to be just what they're looking for. With orders coming in and demand raising, expert Clive Maund shares his view on the potential of this life science company.
Jericho Energy Ventures Inc.'s hydrogen boiler technology creates high-temperature water and steam with no greenhouse gases. The only by-product is water.
Why These Two Analysts Are Following Emerita (08/10/2022)
The latest data from Emerita Resources Corp. may support growth of the company's overall project resource, noted a Clarus Securities report.
Pharma Co. Achieves Record Sales of LEMS Drug in Q2 (08/10/2022)
Shares of Catalyst Pharmaceuticals Inc. traded 24% higher to a new 52-week high after the company reported that in Q2/22 net product revenues from sales of its FIRDAPSE® increased 57.7% YoY to $53.0 million. FIRDAPSE® has been approved by both the U.S. FDA and Health Canada as a treatment for adult patients with Lambert-Eaton myasthenic syndrome, a rare autoimmune disease in which a person's immune system attacks its body's own tissues at the neuromuscular junction.
Aided by the burgeoning drone industry, this company is expected to grow its revenue enough in the next 12 months to move into the black, noted a ThinkEquity report.
Major Uptrending Starting With Droneshield Ltd. (08/09/2022)
Expert Clive Maund reviews the most recent updates with tech co. DroneShield Ltd., a company he believes is at the start of a major uptrend.
Shares of Shockwave Medical Inc. traded 17% higher to a new 52-week high after the company advised that it posted a 116% YoY increase in revenue during Q2/22 and raised the midpoint for its FY/22 revenue guidance by $25 million to $465-475 million.
Junior Not Wasting Time While Waiting for Permits (08/08/2022)
This junior explorer is analyzing samples, conducting fieldwork and geophysical surveys, and mapping its British Columbia site with drones. But it can’t wait to drill and find out what’s underneath.
Agnico Has Strong Quarter: Production Up, Costs Down (08/08/2022)
Expert Adrian Day reviews recent quarterlies and other developments at some more of his favorite gold and silver companies.
W&T Offshore Inc.'s shares traded 17% higher after the oil and gas producer reported Q2/22 financial results featuring a 106% YoY increase in revenue. The company noted it has been successful in increasing its proven reserves, reducing net debt levels, and is continuing to focus on generating free cash flow for shareholders.
First Lithium Minerals Corp. will begin trading on the Canadian Stock Exchange tomorrow, August 9, 2022, under the symbol FLM, following the completion of a reverse takeover of both First Lithium Minerals Inc. and QL Minerals Inc. by First Lithium Minerals Corp. (formerly PetroCorp Group Inc.)
Bear Market Rally Ending Soon (08/08/2022)
A look at recent economic and market indicators that allude to more stagflation and not the outlook mainstream analysts are expecting. In other news, Greenbriar Capital Corp. is negotiating the purchase of a real estate franchise network to compliment its Sage Ranch 995 unit housing development.
Governments all over the world are more concerned than ever about the growing risk from drones that can carry weapons, engage in chemical warfare, and disrupt flights. One Australian company is using technology to mitigate the threat — without ever firing a bullet.
Biotech Co. Awakes To Good News (08/06/2022)
Awakn Life Sciences Corp.'s rating went to an Immediate Speculative Buy after it received substantial funding from the UK government. Expert Clive Maund shares his thoughts on the development.
Biopharma Co. Planning BLA for DMD Drug (08/05/2022)
Sarepta Therapeutics Inc. recently announced that it intends to submit a BLA to the U.S. FDA for its SRP-9001, a gene therapy to treat Duchenne muscular dystrophy. Equity research firm BTIG LLC advised in a research update that SRP-9001 seems to have met the necessary criteria for receiving accelerated approval and it expects an AdCom will be established shortly. BTIG stated that it rates Sarepta Therapeutics as a "Buy" and has a $125 price target for the company's shares.
SRT Device Maker's Revenues Rise 124% in Q2 (08/05/2022)
Sensus Healthcare Inc.'s shares traded 30% higher after the company reported it achieved a 124% YoY increase in revenue in Q2/22. The company advised that demand continues to remain strong for its superficial radiation therapy (SRT) devices which provide minimally invasive and non-surgical alternatives for non-melanoma skin cancer & keloid removal.
Global Equities Offer Yields up to 8% (08/05/2022)
Expert Adrian Day reviews results and developments from some of his favorite non-resource companies. He believes all three are solid dividend payers, and for investors seeking income attractive buys.
After a few weeks of observation, expert Clive Maund believes Bion Environmental Technologies Inc. may be due for a major uptrend and is building up to a major bull market.
This junior releases a preliminary economic assessment focusing on new copper-rich deposits on its massive KSM site in the Golden Triangle.
Shares of Senseonics Holdings Inc. traded 31.5% higher yesterday after the company reported that Elevance Health (formerly Anthem) has approved coverage of its Eversense® E3 implantable continuous glucose monitor to its forty-five million covered members.
Shares of ChemoCentryx Inc. traded 110% higher after the company reported it agreed to be acquired by Amgen Inc. for $52.00 per share in an all-cash deal valued at $4 billion. With the purchase, Amgen aims to cement its leadership position in inflammation and nephrology with the addition of ChemoCentryx's TAVNEOS® (avacopan) which the U.S. FDA approved late last year to treat ANCA-associated vasculitis, a serious autoimmune disease.
Analyst Says PEA Adds 'Considerable Value' to KSM (08/04/2022)
Seabridge Gold Inc.'s copper-rich expansion at its KSM project in the Golden Triangle gets one analyst to raise his target price for the company.
IRadimed Corp. reported Q2/22 financial results that were modestly higher than expected. ROTH Capital Partners LLC advised in a research update that based on the company's higher revenues, improved margins and disciplined cost control measures it is maintaining its Buy rating on IRadimed and raising its price target to $42/share (up from $40).
Expert Clive Maund reviews his opinion on gold and silver junior Western Exploration Inc. after it had what he calls "an impressive rally" in June.
New patents could help Meta Materials Inc. improve safety and reduce the cost of lithium-ion batteries needed for the electric vehicle industry.
Silver Mine Produces While Plant Waits for Power (08/02/2022)
MAG Silver Corp.'s Juanicipio project continues to deliver silver as the company waits for local officials to give the go-ahead to power up its own plant.
Gold Co.'s Stock Price Has Taken a 'Startling Drop' (08/02/2022)
Expert Clive Maund shares the recent drop in Getchell Gold Corp.'s stock price and his rating of the company in light of the news.
Expert Clive Maund gives his assessment of biotech Algernon Pharmaceuticals Inc. after its Phase 2 study of Ifenprodil.
Expert Rates Mining Co. A 'Strong Speculative Buy' (08/02/2022)
Expert Clive Maund shares his assessment of Omineca Mining and Metals Ltd. since its stock is currently inexpensive, and tells you whether he believes this stock is a Buy or a "goodbye."
Expert Believes Health Co. Blooms With Opportunity (08/02/2022)
Expert Clive Maund touches on the latest news with Bloom Health Partners Inc. from the enthusiastic buying toward the end of June to whether he believes the health company is still bullish.
Tech Co. ‘Right at the Point of Breakout' (08/02/2022)
BioLargo Inc. seemed to be very close to breaking out of its tight trading range on July 20, 2022, after remaining in the same place for a month. Expert Clive Maund goes over this update and his assessment of the company after this news.
SunPower Corp. shares traded over 9% higher after the company reported Q2/22 financial results highlighting a 63% YoY increase in revenue. The firm confirmed its previous guidance indicating that it expects to add 73,000 to 80,000 net new customers in FY/2022.
Shares of lithium-ion battery manufacturer Romeo Power Inc. traded 26% higher after the company reported it entered into a definitive agreement to be acquired by commercial EV truck maker Nikola Corp. in an all-stock transaction valued at $144 million.
After Algernon Pharmaceuticals Inc.'s Ifenprodil treatment for chronic cough was reviewed in a Phase 2 analysis, analysts at Research Capital Corp. noted that it is maintaining its Speculative Buy rating on the company.
|"JEV appears to be technically at a very favorable entry point."|
|"This is a good point to add to positions or make new purchases of RHQ."|
|"Data presented by peers at the CTAD conference are relevant to PMN."|
|"LIO announced some more fabulous gold assays from the deep 500 zone."|
|"ROVR optioned two projects: Let's Go and Indian Mountain Lake."|